Cash from Financing (Quarterly) Chart

View Cash from Financing (Quarterly) for TRGM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Financing (Quarterly) Chart
Start Trial

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2010. Start Trial.
Date Value
December 31, 2015 -0.0145M
September 30, 2015 -0.133M
June 30, 2015 -0.1799M
March 31, 2015 1.677M
December 31, 2014 -0.2665M
September 30, 2014 -0.1731M
June 30, 2014 -0.4985M
March 31, 2014 -0.3223M
December 31, 2013 2.185M
September 30, 2013 0.0323M
June 30, 2013 0.3407M
Date Value
March 31, 2013 -0.225M
December 31, 2012 0.135M
September 30, 2012 -0.155M
June 30, 2012 1.598M
March 31, 2012 1.27M
December 31, 2011 0.67M
September 30, 2011 1.085M
June 30, 2011 0.45M
March 31, 2011 0.00
December 31, 2010 0.30M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
Cardax, Inc. --
Acusphere, Inc. --
Aeolus Pharmaceuticals, Inc. --
RVL Pharmaceuticals Plc --
Baudax Bio, Inc. --